The DOI matches its Crossref record; 1,861 of the 1,959 references it cites were found in a registry or an index; 7 of the 11 sources its claims cite were checked for support.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Open accessAbstract
Objective The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and stakeholders, and individuals with diabetes and their caregivers. Methods The American Association of Clinical Endocrinology selected a task force of medical experts and staff who updated and assessed clinical questions and recommendations from the prior 2015 version of this guideline and conducted literature searches for relevant scientific papers published from January 1, 2015, through May 15, 2022. Selected studies from results of literature searches composed the evidence base to update 2015 recommendations as well as to develop new recommendations based on review of clinical evidence, current practice, expertise, and consensus, according to established American Association of Clinical Endocrinology protocol for guideline development. Results This guideline includes 170 updated and new evidence-based clinical practice recommendations for the comprehensive care of persons with diabetes. Recommendations are divided into four sections: (1) screening, diagnosis, glycemic targets, and glycemic monitoring; (2) comorbidities and complications, including obesity and management with lifestyle, nutrition, and bariatric surgery, hypertension, dyslipidemia, retinopathy, neuropathy, diabetic kidney disease, and cardiovascular disease; (3) management of prediabetes, type 2 diabetes with antihyperglycemic pharmacotherapy and glycemic targets, type 1 diabetes with insulin therapy, hypoglycemia, hospitalized persons, and women with diabetes in pregnancy; (4) education and new topics regarding diabetes and infertility, nutritional supplements, secondary diabetes, social determinants of health, and virtual care, as well as updated recommendations on cancer risk, nonpharmacologic components of pediatric care plans, depression, education and team approach, occupational risk, role of sleep medicine, and vaccinations in persons with diabetes. Conclusions This updated clinical practice guideline provides evidence-based recommendations to assist with person-centered, team-based clinical decision-making to improve the care of persons with diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 of 11 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“A glucose level ≥200 mg/dL in the presence of hyperglycemia symptoms such as polyuria and polydipsia confirm the diagnosis of DM.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Evidence Base 1: How is the diagnosis of DM made and what is the current screening protocol for prediabetes and DM?
What the sources say
- Could not verifycites [6] sourceExperimental — accuracy not yet measured
The Diagnostic testing passage (page unavailable) discusses fasting glucose, HbA1c, C-peptide, and antibody tests for evaluating MODY. Neither it nor the other retrieved passages gives a ≥200 mg/dL glucose threshold with hyperglycemia symptoms for diagnosing diabetes; searches for that threshold and symptom-based criterion found no supporting passage in our copy. (LLM, conf=0.73)
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The concordance between FPG, 2-hour PG, and A1C is not perfect; thus, the diagnosis of DM requires 2 different (fasting glucose and A1C) abnormal test results, either from the same sample or 2 abnormal results on samples drawn on different days.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Evidence Base 1: How is the diagnosis of DM made and what is the current screening protocol for prediabetes and DM?
What the sources say
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The paper’s introductory passage says diabetes diagnosis requires confirmation of an elevated glucose or HbA1c result and that two different tests above diagnostic thresholds can provide confirmation. It also says repeating the same test on a later sample is preferred, so two different tests are not required. The Discussion says guidelines were unclear about using two tests from one sample; our copy does not address the quoted exception for symptoms with glucose of at least 200 mg/dL or concordance involving 2-hour PG. (LLM, conf=0.87)
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The paper’s opening section says that FPG or 2-hour glucose meets the usual diagnostic criteria when abnormal on more than one occasion, and that classic symptoms with a single random plasma glucose of at least 200 mg/dL are diagnostic. It does not say that confirmation requires two different tests (FPG and A1C), or that two abnormal results from the same sample suffice. Its discussion of test variability supports imperfect reproducibility, but not that specific confirmation rule. (LLM, conf=0.88)
- Partly supportedcites [5] sourceExperimental — accuracy not yet measured
The Discussion reports imperfect agreement among HbA1c, fasting plasma glucose, and 2-hour plasma glucose, and says diabetes diagnosis requires repeated measurement rather than a single test. It does not specify that the two abnormal results must be from different tests, describe the same-sample or different-day options, or state an exception for hyperglycemic symptoms with glucose of at least 200 mg/dL. (LLM, conf=0.88)
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Evidence Base 1: How is the diagnosis of DM made and what is the current screening protocol for prediabetes and DM?
What the sources say
- Not matchedcites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [50] sourceExperimental — accuracy not yet measured
The Conclusions recommend GDM screening at 24–28 weeks using a 75-g OGTT. The paper does not compare universal screening with risk-factor-based selective screening or report that universal screening is cost-effective; searches for selective screening and cost-effectiveness found no such comparison. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [51] source
- Not checked — no full text of the sourcecites [52] source
- Not checked — no full text of the sourcecites [53] source
- Partly supportedcites [54] sourceExperimental — accuracy not yet measured
Section 5.2 recommends universal testing because risk-factor-based selective testing has poor sensitivity for detecting GDM. But section 5.4 says there is a lack of good evidence for the cost-effectiveness of universal testing in both high- and low-resource countries; it does not establish that universal screening is cost-effective compared with selective screening. (LLM, conf=0.90)
- Could not verifycites [55] sourceExperimental — accuracy not yet measured
The Conclusions discuss childhood glucose outcomes after maternal GDM, not whether universal screening is recommended. Searches of our copy for selective screening, missed cases, and cost-effectiveness found no passage addressing those claims. (LLM, conf=0.76)
- Not matched
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Real-time CGM (rtCGM) or isCGM is recommended for all persons with T1D, regardless of insulin delivery system, to improve A1C levels and to reduce the risk for hypoglycemia and DKA.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Question 3: When and how should glucose monitoring be used?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“DM is diagnosed by using any of 3 established criteria for elevated blood glucose (BG) concentrations (Table 4). FPG ≥126 mg/dL, 2-hour PG ≥ 200 mg/dL during 75-g OGTT, and A1C ≥ 6.5% are equally appropriate for diagnostic screening (Table 4).”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Evidence Base 1: How is the diagnosis of DM made and what is the current screening protocol for prediabetes and DM?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For most hospitalized persons with hyperglycemia in both the intensive care unit (ICU) and non-ICU settings, a glucose range of 140 to 180 mg/dL is recommended, provided this target can be safely achieved (Table 6).”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Question 2. What are the glycemic treatment goals for persons with DM?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Diabetic peripheral neuropathy (DPN) is a clinical diagnosis. A comprehensive differential diagnosis should be considered to rule out nondiabetic neuropathies.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Section 2: Comorbidities and Complications > Question 8: How should neuropathy be diagnosed and managed in persons with DM?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All persons who use insulin should use CGM or perform BG monitoring (BGM) a minimum of twice daily and ideally before any insulin injection.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Question 3: When and how should glucose monitoring be used?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A1C should be measured at least semiannually in all persons with DM and at least quarterly in persons not at their glycemic target.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Recommendations and Evidence Bases > Question 3: When and how should glucose monitoring be used?
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Screening for DPN should be done at diagnosis of T2D, within 5 years of the diagnosis of T1D, and subsequently annually or whenever symptoms occur, by performing a clinical history and physical exam.”
§ American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland—2022 Update > Section 2: Comorbidities and Complications > Question 8: How should neuropathy be diagnosed and managed in persons with DM?
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous access to CGM for daily use is suggested for people living with T2DM at higher risk of hypoglycaemia, similar to the current CGM clinical practice guideline recommendations from Diabetes Canada 56 and the American Association of Clinical Endocrinologists. 57”
From Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials (2025) · cites this paper as [57]
Experimental — accuracy not yet measuredIn the citing paper
“Approximately 2–5 times more patients discontinued orforglipron versus placebo due to adverse events, comparable to other GLP‐1 receptor agonists where 5%–15% discontinue in clinical trials [48].”
From Efficacy and Safety of Orforglipron in Obese Adults With or Without Diabetes: A Systematic Review and Meta‐Analysis (2025) · cites this paper as [48]
In the citing paper
“Current guideline recommendations by the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), American College of Sports Medicine (ACSM), American Association of Clinical Endocrinology (AACE), and the American Heart Association (AHA) advocate regular resistance and aerobic exercise, as well as physical activity such as increasing daily steps to avoid sed”
From The Impact of Physical Activity in Patients With Type 2 Diabetes (2025) · cites this paper as [23]
In the citing paper
“AACE and the ADA recommend avoiding no more than 2 to 3 days between exercise routines to maintain improvement in insulin sensitivity.”
From The Impact of Physical Activity in Patients With Type 2 Diabetes (2025) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
CKD recommendation and rationale give different SGLT2i eligibility thresholds
MajorRecommendation 6.4 covers people with T2D and CKD whose eGFR is at least 20, but its evidence base sets the general threshold above 25. The lower threshold is described there only for empagliflozin in people with heart failure, leaving those without heart failure between 20 and 25 covered by the recommendation but not the stated general rule.
“An SGLT2i with proven benefit is recommended as foundational therapy for persons with T2D and CKD with eGFR ≥20 mL/min/1.73 m2 to reduce progression of CKD and risk of CVD.”
“An SGLT2i with proven kidney protection is recommended for people with T2D who have an eGFR >25 mL/min/1.73 m2 irrespective of albuminuria to reduce risks of DKD or CKD in DM and CVD.425,443–469 In those with HF, one agent in the class, empagliflozin, can be used with an eGFR as low as 20 mL/min/1.73 m2.”
GDM fasting threshold differs at 92 mg/dL
MinorThe one-step diagnostic recommendation includes a fasting glucose of exactly 92 mg/dL, while the later diagnostic criteria require a value greater than 92 mg/dL. The two rules classify a patient at that boundary differently.
“The one-step approach uses a 2-hour 75-g oral glucose tolerance test (OGTT) after ≥8 hours of fasting with diagnostic cutoffs of one or more FPG ≥92 mg/dL, 1-hour PG ≥180 mg/dL, or 2-hour PG ≥153 mg/dL.”
“Glucose criteria diagnostic for GDM are an FPG >92 mg/dL, 1-hour postglucose challenge value ≥180 mg/dL, or 2-hour value ≥153 mg/dL.”
Semaglutide weekly dose changes by a factor of 1,000
MinorThe same discussion gives the higher weekly semaglutide dose as 2.4 mg and then describes an equivalent weekly dose as 2.4 g. Those quantities differ by a factor of 1,000.
“A phase 2 study in persons with biopsy-proven NASH using a daily injection equivalent to semaglutide 2.4 g/week demonstrated 13% weight loss”
“Subcutaneous semaglutide at the higher dose of 2.4 mg/week has been approved for chronic weight management”
Diabetes confirmation alternates between two results and two different tests
MinorRecommendation 1.1 permits two abnormal results on different days without requiring different tests. Its evidence base instead says confirmation requires two different tests, specifically fasting glucose and A1C, so the rules disagree on whether repeating one test suffices.
“Diagnosis of DM requires 2 abnormal test results, either from the same sample or 2 abnormal results on samples drawn on different days.”
“the diagnosis of DM requires 2 different (fasting glucose and A1C) abnormal test results, either from the same sample or 2 abnormal results on samples drawn on different days.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1016/j.diabres.2021.108972
MajorThe cited work was retracted on 2021-07-31 (notice 10.1016/j.diabres.2021.108972), before this paper was published (2022-10). Its authors could have known.
Cited work 10.1016/j.diabres.2021.108972 · retracted 2021-07-31 · notice 10.1016/j.diabres.2021.108972 · this paper published 2022-10
“Adler, 2021, Reprint of: Classification of diabetes mellitus, Diabetes Res Clin Pract, 10.1016/j.diabres.2021.108972”
Citations
Cites
1 retracted
Items 1,201–1,400 of 1,862
Body fatness at an early age and risk of colorectal cancer
Hidayat, K., Yang, C., & Shi, B. (2018) · International Journal of Cancer · doi:10.1002/ijc.31100 · Cited by 71
Overbeek, J. A., Bakker, M., van der Heijden, A. A. W. A., van Herk‐Sukel, M. P. P., Herings, R. M. C., & Nijpels, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3004 · Cited by 71
Ballmann, M., Hubert, D., Assael, B. M., Staab, D., Hebestreit, A., Naehrlich, L., Nickolay, T., Prinz, N., Holl, R. W., Staden, U., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30400-x · Cited by 71
Razaz, J. M., Rahmani, J., Varkaneh, H. K., Thompson, J., Clark, C., & Abdulazeem, H. M. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.05.001 · Cited by 71
Persson, F., Bain, S. C., Mosenzon, O., Heerspink, H. J. L., Mann, J. F. E., Pratley, R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1622 · Cited by 71
Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment
Schafers, S., Naunheim, R., Vijayan, A., & Tobin, G. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.977 · Cited by 70
Freckmann, G., Schmid, C., Baumstark, A., Rutschmann, M., Haug, C., & Heinemann, L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815580160 · Cited by 70
Schlesinger, S., Lieb, W., Koch, M., Fedirko, V., Dahm, C. C., Pischon, T., Nöthlings, U., Boeing, H., & Aleksandrova, K. (2015) · Obesity Reviews · doi:10.1111/obr.12286 · Cited by 70
den Uyl, D., van Raalte, D. H., Nurmohamed, M. T., Lems, W. F., Bijlsma, J. W. J., Hoes, J. N., Dijkmans, B. A. C., & Diamant, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33378 · Cited by 70
Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney disease
Kuo, I.-C., Lin, H. Y.-H., Niu, S.-W., Hwang, D.-Y., Lee, J.-J., Tsai, J.-C., Hung, C.-C., Hwang, S.-J., & Chen, H.-C. (2016) · Scientific Reports · doi:10.1038/srep20028 · Cited by 70
DIEHL, L. A., de Souza, R. M., GORDAN, P. A., Esteves, R. Z., & Coelho, I. C. M. M. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6944 · Cited by 70
A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence
Abughosh, S., Wang, X., Serna, O., Esse, T. W., Mann, A., Masilamani, S., Holstad, M. M., Essien, E. J., & Fleming, M. L. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.5.549 · Cited by 70
Akturk, H. K., Snell-Bergeon, J. K., Rewers, A., Klaff, L. J., Bode, B. W., Peters, A. L., Bailey, T. S., & Garg, S. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0200 · Cited by 70
French, S. A., Sherwood, N. E., Veblen-Mortenson, S., Crain, A. L., JaKa, M. M., Mitchell, N. R., Hotop, A. M., Berge, J. M., Kunin Batson, A. S., Truesdale, K., et al. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304696 · Cited by 70
Mora, S., Chang, C. L., Moorthy, M. V., & Sever, P. S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0392 · Cited by 70
Corona, G., Rastrelli, G., Balercia, G., Lotti, F., Sforza, A., Monami, M., Forti, G., Mannucci, E., & Maggi, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02717.x · Cited by 69
Spanakis, E. K., Levitt, D. L., Siddiqui, T., Singh, L. G., Pinault, L. F., Sorkin, J. D., Umpierrez, G. E., & Fink, J. C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817748964 · Cited by 69
Self-citationDiabetes transition care and adverse events: A population-based cohort study in Ontario, Canada
Shulman, R., Shah, B. R., Fu, L., Chafe, R., & Guttmann, A. (2018) · Diabetic Medicine · doi:10.1111/dme.13782 · Cited by 69
Blevins, T., Zhang, Q., Frias, J. P., Jinnouchi, H., & Chang, A. M. (2020) · Diabetes Care · doi:10.2337/dc19-2550 · Cited by 69
Giugliano, D., Longo, M., Caruso, P., Di Fraia, R., Scappaticcio, L., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2021) · Diabetes Care · doi:10.2337/dc20-2623 · Cited by 69
Chen, T., Jia, H., Li, J., Chen, X., Zhou, H., & Tian, H. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00804.x · Cited by 68
Herman, W. H. (2016) · Diabetes Care · doi:10.2337/dc15-2686 · Cited by 68
Wissing, K. M., Abramowicz, D., Weekers, L. E., Budde, K., Rath, T., Witzke, O., Broeders, N., Kianda, M. N., & Kuypers, D. R. J. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14665 · Cited by 68
Li, S., Chen, L., Jin, W., Ma, X., Ma, Y., Dong, F., Zhu, H., Li, J., & Wang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-18278-x · Cited by 68
Bursell, S.-E., Fonda, S. J., Lewis, D. G., & Horton, M. B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198551 · Cited by 68
Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
Apel, J., Reutrakul, S., & Baldwin, D. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu026 · Cited by 67
Hansen, A. B., Hartvig, N. V., Jensen, M. S., Borch‐Johnsen, K., Lund‐Andersen, H., & Larsen, M. (2004) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2004.00350.x · Cited by 67
Wagner, J. A., Bermudez-Millan, A., Damio, G., Segura-Perez, S., Chhabra, J., Vergara, C., Feinn, R., & Perez-Escamilla, R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.022 · Cited by 67
Liu, L., Simon, B., Shi, J., Mallhi, A. K., & Eisen, H. J. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i18.449 · Cited by 67
Hegedüs, L., Sherman, S. I., Tuttle, R. M., von Scholten, B. J., Rasmussen, S., Karsbøl, J. D., Daniels, G. H., & for the LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1956 · Cited by 67
Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients
Aggarwal, R., Petrie, B., Bala, W., & Chiu, N. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12697 · Cited by 67
Khan, S. U., Khan, M. U., Valavoor, S., Khan, M. S., Okunrintemi, V., Mamas, M. A., Leucker, T. M., Blaha, M. J., & Michos, E. D. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319871733 · Cited by 67
Mathioudakis, N. N., Abusamaan, M. S., Shakarchi, A. F., Sokolinsky, S., Fayzullin, S., McGready, J., Zilbermint, M., Saria, S., & Golden, S. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.30913 · Cited by 67
The impact of vegan diet in the prevention and treatment of type 2 diabetes: A systematic review
Pollakova, D., Andreadi, A., Pacifici, F., Della-Morte, D., Lauro, D., & Tubili, C. (2021) · Nutrients · doi:10.3390/nu13062123 · Cited by 67
Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)
Masson, E. A., Patmore, J., Brash, P. D., Baxter, M., Caldwell, G., GALLEN, I. W., Price, P. A., Vice, P., Walker, J. D., & Lindow, S. W. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00840.x · Cited by 66
Russell-Jones, D., Gall, M.-A., Niemeyer, M., Diamant, M., & Del Prato, S. (2015) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.06.005 · Cited by 66
Siaw, M. Y. L., & Lee, J. V. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13288 · Cited by 66
Riddle, M., Pencek, R., Charenkavanich, S., Lutz, K., Wilhelm, K., & Porter, L. (2009) · Diabetes Care · doi:10.2337/dc09-0395 · Cited by 66
Tight glycemic control and computerized decision-support systems: a systematic review
Eslami, S., Abu–Hanna, A., de Jonge, E., & de Keizer, N. F. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1542-0 · Cited by 66
Munshi, M. N., Slyne, C., Greenberg, J. M., Greaves, T., Lee, A., Carl, S., Atakov-Castillo, A., & Toschi, E. (2019) · Diabetes Care · doi:10.2337/dc18-1631 · Cited by 66
Diabetes mellitus and functional sperm characteristics: A meta-analysis of observational studies
Pergialiotis, V., Prodromidou, A., Frountzas, M., Korou, L. M., Vlachos, G. D., & Perrea, D. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.002 · Cited by 65
Management of type 1 diabetes in pregnancy
Feldman, A. Z., & Brown, F. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0765-z · Cited by 65
Bramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Seufert, J., Danne, T., & Holl, R. W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0837-x · Cited by 65
Noronha, J. C., Nishi, S. K., Braunstein, C. R., Khan, T. A., Blanco Mejia, S., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Leiter, L. A., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2270 · Cited by 65
GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis
Malhotra, K., Katsanos, A. H., Lambadiari, V., Goyal, N., Palaiodimou, L., Kosmidou, M., Krogias, C., Alexandrov, A. V., & Tsivgoulis, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09813-4 · Cited by 65
Ferguson, S., Swan, M., & Smaldone, A. M. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715584404 · Cited by 64
Aguiar, P. M., da Silva, C. H. P., Chiann, C., Dórea, E. L., de Lyra, D. P., & Storpirtis, S. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12606 · Cited by 64
New-Onset Diabetes After Acute and Critical Illness
Jivanji, C. J., Asrani, V. M., Windsor, J. A., & Petrov, M. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.12.020 · Cited by 64
Wong, C. A., Miller, V. A., Murphy, K., Small, D., Ford, C. A., Willi, S. M., Feingold, J., Morris, A., Ha, Y. P., Zhu, J., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.3233 · Cited by 64
A systematic review and meta-analysis of tai chi for treating type 2 diabetes
Lee, M. S., Jun, J. H., Lim, H.-J., & Lim, H.-S. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.09.008 · Cited by 63
Blood pressure control for diabetic retinopathy
Diana, V., Wang, X., Vedula, S. S., Marrone, M. T., Sleilati, G. G., Hawkins, B. S., & Frank, R. N. (2015) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.20151333t1 · Cited by 63
Grimm, M., Han, J., Weaver, C., Griffin, P., Schulteis, C. T., Dong, H., & Malloy, J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2660 · Cited by 63
Benhalima, K., Mathieu, C., Van Assche, A., Damm, P., Devlieger, R., Mahmood, T., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.003 · Cited by 63
Jeong, J. Y., Jeon, J.-H., Bae, K.-H., Choi, Y.-K., Park, K.-G., Kim, J.-G., Won, K. C., Cha, B. S., Ahn, C. W., Kim, D. W., et al. (2018) · Telemedicine and e-Health · doi:10.1089/tmj.2017.0203 · Cited by 63
Honsek, C., Kabisch, S., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Dambeck, U., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H. (2018) · Diabetologia · doi:10.1007/s00125-018-4582-6 · Cited by 63
Rosenstock, J., Emral, R., Sauque-Reyna, L., Mohan, V., Trescolí, C., Al Sifri, S., Lalic, N., Alvarez, A., Picard, P., Bonnemaire, M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0393 · Cited by 63
Lepard, M. G., Joseph, A. L., Agne, A. A., & Cherrington, A. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0608-3 · Cited by 62
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial
Leehey, D. J., Zhang, J. H., Emanuele, N. V., Whaley-Connell, A., Palevsky, P. M., Reilly, R. F., Guarino, P., & Fried, L. F. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02850315 · Cited by 62
Pancreatic Safety of Sitagliptin in the TECOS Study
Buse, J. B., Bethel, M. A., Green, J. B., Stevens, S. R., Lokhnygina, Y. V., Aschner, P. J., Grado, C. A. R., Tankova, T. I., Wainstein, J., Josse, R., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2780 · Cited by 62
Diabetes technology in the inpatient setting for management of hyperglycemia
Davis, G. M., Galindo, R. J., Migdal, A. L., & Umpierrez, G. E. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.002 · Cited by 62
Self-citationAkbari, M., Tamtaji, O. R., Lankarani, K. B., Tabrizi, R., Dadgostar, E., Haghighat, N., Kolahdooz, F., Ghaderi, A., Mansournia, M. A., & Asemi, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-1198-x · Cited by 62
Wolf, R. M., Liu, T. Y. A., Thomas, C., Prichett, L., Zimmer-Galler, I., Smith, K., Abramoff, M. D., & Channa, R. (2021) · Diabetes Care · doi:10.2337/dc20-1671 · Cited by 62
Hood, R. C., Arakaki, R. F., Wysham, C., Li, Y. G., Settles, J. A., & Jackson, J. A. (2015) · Endocrine Practice · doi:10.4158/ep15612.or · Cited by 61
Kato, S., Maruyama, S., Makino, H., Wada, J., Ogawa, D., Uzu, T., Araki, H., Koya, D., Kanasaki, K., Oiso, Y., et al. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1106-2 · Cited by 61
Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study
Roux, J. A. F., Colet, J. C., Pedro‐Botet, J., Benaiges, D., de Dou, J. P., Chillarón, J. J., Goday, A., Bruguera, J., & Cano-Pérez, J. F. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-39 · Cited by 61
Body mass index and lung cancer risk in never smokers: A meta-analysis
Zhu, H., & Zhang, S. (2018) · BMC Cancer · doi:10.1186/s12885-018-4543-y · Cited by 61
Melo, K., Bahia, L., Pasinato, B. P. R., Porfírio, G. J. M., Martimbianco, A. L. C., Riera, R., Calliari, L. E., Minicucci, W. J., Turatti, L. A. A., Pedrosa, H. C., et al. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0397-3 · Cited by 61
Maguire, M. G., Liu, D., Glassman, A. R., Jampol, L. M., Johnson, C. A., Baker, C. W., Bressler, N. M., Gardner, T. W., Pieramici, D., Stockdale, C. R., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.5939 · Cited by 61
Self-citationCharacteristics of maturity onset diabetes of the young in a large diabetes center
Chambers, C., Fouts, A., Dong, F., Colclough, K., Wang, Z., Batish, S. D., Jaremko, M., Ellard, S., Hattersley, A. T., KLINGENSMITH, G. J., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12289 · Cited by 60
Frequent monitoring of A1c during pregnancy as a treatment tool to guide therapy
Jovanovič, L., Savas, H., Mehta, M., Trujillo, A., & Pettitt, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1455 · Cited by 60
Sun, C., Malcolm, J., Wong, B., Shorr, R., & Doyle, M.-A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.03.010 · Cited by 60
Beato-Víbora, P. I., Quirós-López, C., Lázaro-Martín, L., Martín-Frías, M., Barrio-Castellanos, R., Gil-Poch, E., Arroyo-Díez, F. J., & Giménez-Álvarez, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0199 · Cited by 60
Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1842 · Cited by 60
Self-citationVaccines for preventing herpes zoster in older adults
Gagliardi, A. M., Andriolo, B. N., Torloni, M. R., Soares, B. G., Gomes, J. D. O., Andriolo, R. B., & Cruz, E. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008858.pub4 · Cited by 60
Scott, I. U., Jackson, G. R., Quillen, D. A., Larsen, M., Klein, R., Liao, J., Holfort, S., Munch, I. C., & Gardner, T. W. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.93 · Cited by 59
Self-citationHe, X.-K., Su, T.-T., Si, J.-M., & Sun, L.-M. (2016) · Medicine · doi:10.1097/md.0000000000002749 · Cited by 59
Rasmussen, O. W., Lauszus, F., & Loekke, M. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x15608984 · Cited by 59
Bermúdez-Millán, A., Pérez-Escamilla, R., Segura-Pérez, S., Damio, G., Chhabra, J., Osborn, C. Y., & Wagner, J. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.231365 · Cited by 59
Karnchanasorn, R., Huang, J., Ou, H.-Y., Feng, W., Chuang, L.-M., Chiu, K. C., & Samoa, R. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6195494 · Cited by 59
Edwardson, C. L., Henson, J., Bodicoat, D. H., Bakrania, K., Khunti, K., Davies, M. J., & Yates, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014267 · Cited by 59
Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., McKnight, J. M., Green, F., Collier, A., McKeigue, P. M., & Colhoun, H. M. (2020) · Diabetes Care · doi:10.2337/dc19-1582 · Cited by 59
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
Fang, M., & Selvin, E. (2021) · Diabetes Care · doi:10.2337/dc20-2304 · Cited by 59
Khan, K. S., & Andersen, H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997921 · Cited by 59
Metformin and cancer in type 2 diabetes: A systematic review and comprehensive bias evaluation
Farmer, R. E., Ford, D., Forbes, H. J., Chaturvedi, N., Kaplan, R., Smeeth, L., & Bhaskaran, K. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx046 · Cited by 59
Odawara, M., Miyagawa, J., Iwamoto, N., Takita, Y., Imaoka, T., & Takamura, T. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12602 · Cited by 58
Lapolla, A., Dalfrà, M. G., Spezia, R., Anichini, R., Bonomo, M., Bruttomesso, D., Di Cianni, G., Franzetti, I., Galluzzo, A., Mello, G., et al. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0024-0 · Cited by 58
Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia.
Stagnaro‐Green, A., Barton, M. K., Linekin, P. L., Corkery, E. W., deBeer, K., & Roman, S. H. (1995) · PubMed · Cited by 58
on behalf of the CHANCES consortium, Arnold, M., Freisling, H., Stolzenberg-Solomon, R., Kee, F., O’Doherty, M. G., Ordóñez-Mena, J. M., Wilsgaard, T., May, A. M., Bueno-de-Mesquita, H. B., et al. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0169-z · Cited by 58
Teleconsultation in type 1 diabetes mellitus (TELEDIABE)
Bertuzzi, F., Stefani, I., Rivolta, B., Pintaudi, B., Meneghini, E., Luzi, L., & Mazzone, A. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1084-9 · Cited by 58
Sathiyakumar, V., Park, J., Quispe, R., Elshazly, M. B., Michos, E. D., Banach, M., Toth, P. P., Whelton, S. P., Blumenthal, R. S., Jones, S. R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032463 · Cited by 58
Metabolic syndrome in male hypogonadism
Rastrelli, G., Filippi, S., Sforza, A., Maggi, M., & Corona, G. (2018) · Frontiers of Hormone Research · doi:10.1159/000485999 · Cited by 58
Soltero, E. G., Olson, M. L., Williams, A. N., Konopken, Y. P., Castro, F. G., Arcoleo, K. J., Keller, C. S., Patrick, D. L., Ayers, S. L., Barraza, E., et al. (2018) · Obesity · doi:10.1002/oby.22300 · Cited by 58
Samuelsson, U., Anderzén, J., Guðbjörnsdóttir, S., Steineck, I. I. K., Åkesson, K., & Hanberger, L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.007 · Cited by 57
Orlov, S., Cherney, D. Z. I., Pop-Busui, R., Lovblom, L. E., Ficociello, L. H., Smiles, A. M., Warram, J. H., Krolewski, A. S., & Perkins, B. A. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11441114 · Cited by 57
Self-citationThe association between BMI and gallbladder cancer risk: A meta-analysis
Li, Z.-M., Wu, Z.-X., Han, B., Mao, Y.-Q., Chen, H.-L., Han, S.-F., Xia, J.-L., & Wang, L.-S. (2016) · Oncotarget · doi:10.18632/oncotarget.9664 · Cited by 57
Chen, L., Kuang, J., Pei, J.-H., Chen, H.-M., Chen, Z., Li, Z.-W., Yang, H.-Z., Fu, X.-Y., Wang, L., Chen, Z.-J., et al. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.11.010 · Cited by 57
Christensen, M. B., Gotfredsen, A., & Nørgaard, K. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2885 · Cited by 57
Hu, Y., Wen, X., Wang, F., Yang, D., Liu, S., Li, P., & Xu, J. (2019) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x18776823 · Cited by 57
Wan, G., Sun, X., Li, F., Wang, X., Li, C., Li, H., Yu, X., & Cao, F. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493214 · Cited by 57
Moelands, S. V., Lucassen, P. L., Akkermans, R. P., De Grauw, W. J., & Van de Laar, F. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005061.pub3 · Cited by 57
Lake, A., Arthur, A., Byrne, C., Davenport, K., Yamamoto, J. M., & Murphy, H. R. (2019) · Diabetic Medicine · doi:10.1111/dme.14115 · Cited by 57
Clement, M., Filteau, P., Harvey, B., Jin, S., Laubscher, T., Mukerji, G., & Sherifali, D. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.005 · Cited by 57
Weisz, B., Shrim, A., Homko, C. J., Schiff, E., Epstein, G. S., & Sivan, E. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211243 · Cited by 56
Pettitt, D. J., & Jovanovic, L. (2007) · Diabetes Care · doi:10.2337/dc07-s207 · Cited by 56
Do Race and Ethnicity Impact Hemoglobin A1c Independent of Glycemia?
Herman, W. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300406 · Cited by 56
Paz-Pacheco, E., Sandoval, M. A., Ardena, G. J. R., Paterno, E., Juban, N., Lantion-Ang, F. L., Jimeno, C., Patal, P., & Bongon, J. (2017) · Primary Health Care Research & Development · doi:10.1017/s1463423616000335 · Cited by 56
Meng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56
Hu, J., Chen, J.-B., Cui, Y., Zhu, Y.-W., Ren, W.-B., Zhou, X., Liu, L.-F., Chen, H.-Q., & Zu, X.-B. (2018) · Medicine · doi:10.1097/md.0000000000011596 · Cited by 56
Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., Harrap, S., Mancia, G., Marre, M., Neal, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12060 · Cited by 56
Dai, X., Zhai, L., Chen, Q., Miller, J. D., Lu, L., Hsue, C., Liu, L., Yuan, X., Wei, W., Ma, X., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3143 · Cited by 56
de Groot, M., Shubrook, J. H., Hornsby, W. G., Pillay, Y., Mather, K. J., Fitzpatrick, K., Yang, Z., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2400 · Cited by 56
Metsärinne, K., Bröijersen, A., Kantola, I., Niskanen, L., Rissanen, A., Appelroth, T., Pöntynen, N., Poussa, T., Koivisto, V., & Virkamäki, A. (2015) · Primary Care Diabetes · doi:10.1016/j.pcd.2014.06.001 · Cited by 55
Pasquel, F. J., Gomez-Huelgas, R., Anzola, I., Oyedokun, F., Haw, J. S., Vellanki, P., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-1835 · Cited by 55
Self-citationPereira, A. C., Gomez, L. M., Bittencourt, M. S., Staniak, H. L., Sharovsky, R., Foppa, M., Blaha, M. J., Bensenor, I. M., & Lotufo, P. A. (2016) · Clinical Cardiology · doi:10.1002/clc.22539 · Cited by 55
Tran, S., Retnakaran, R. R., Zinman, B., & Kramer, C. K. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13137 · Cited by 55
Vaz, E. C., Porfírio, G. J. M., Nunes, H. R. D. C., & Nogueira, V. D. S. N. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000045 · Cited by 55
Update on the Management of Diabetic Neuropathy
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0036 · Cited by 55
Self-citationGriffin, S. J., Rutten, G. E. H. M., Khunti, K., Witte, D. R., Lauritzen, T., Sharp, S. J., Dalsgaard, E.-M., Davies, M. J., Irving, G. J., Vos, R. C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30349-3 · Cited by 55
Abdul-Ghani, M., Puckett, C., Adams, J., Khattab, A., Baskoy, G., Cersosimo, E., Triplitt, C., & DeFronzo, R. A. (2021) · Diabetes Care · doi:10.2337/dc20-0978 · Cited by 55
Self-citationOtis, J. D., Sanderson, K., Hardway, C., Pincus, M., Tun, C., & Soumekh, S. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.12.013 · Cited by 54
Persson, F., Lindhardt, M., Rossing, P., & Parving, H.-H. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316652047 · Cited by 54
Warren, R., Carlisle, K., Mihala, G., & Scuffham, P. A. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17723943 · Cited by 54
Crawford, M. R., Pham, N. N., Khan, L. A., Bena, J. F., Schauer, P. R., & Kashyap, S. R. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0072 · Cited by 54
Agarwal, S., Raymond, J. K., Isom, S., Lawrence, J. M., Klingensmith, G., Pihoker, C., Corathers, S., Saydah, S., D'Agostino, R. B., & Dabelea, D. (2018) · Diabetic Medicine · doi:10.1111/dme.13589 · Cited by 54
Majdinasab, N., Kaveyani, H., & Azizi, M. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s185995 · Cited by 54
Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late
Levinsky, N. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00016 · Cited by 53
Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12282 · Cited by 53
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
Henry, R. R., Chilton, R., & Garvey, W. T. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.011 · Cited by 53
Self-citationShi, J., Xiong, L., Li, J., Cao, H., Jiang, W., Liu, B., Chen, X., Liu, C., Liu, K., Wang, G., et al. (2015) · Scientific Reports · doi:10.1038/srep17591 · Cited by 53
Konishi, H., Miyauchi, K., Shitara, J., Endo, H., Wada, H., Doi, S., Naito, R., Tsuboi, S., Ogita, M., Dohi, T., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.067 · Cited by 53
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
Farmer, R. E., Ford, D., Forbes, H. J., Chaturvedi, N., Kaplan, R. S., Smeeth, L. L., & Bhaskaran, K. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw275 · Cited by 53
Campbell, F., Lawton, J., Rankin, D., Clowes, M., Coates, E., Heller, S., de Zoysa, N., Elliott, J., & Breckenridge, J. P. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3655-z · Cited by 53
Feng, Y., Huang, R., Kavanagh, J., Li, L., Zeng, X., Li, Y., & Fu, P. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-00321-5 · Cited by 53
Diagnostic Accuracy of Technology-based Eye Care Services
Maa, A. Y., Medert, C. M., Lu, X., Janjua, R., Howell, A. V., Hunt, K. J., McCord, S., Giangiacomo, A., & Lynch, M. G. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.07.026 · Cited by 53
Ruiz de Adana, M. S., Alhambra-Expósito, M. R., Muñoz-Garach, A., Gonzalez-Molero, I., Colomo, N., Torres-Barea, I., Aguilar-Diosdado, M., Carral, F., Serrano, M., Martínez-Brocca, M. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0739 · Cited by 53
Cardiovascular autonomic neuropathy: A silent killer with long reach
Ang, L., Dillon, B., Mizokami-Stout, K., & Pop-Busui, R. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102646 · Cited by 53
Self-citationGalindo, R. J., Ali, M. K., Funni, S. A., Dodge, A. B., Kurani, S. S., Shah, N. D., Umpierrez, G. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1579 · Cited by 53
Self-citationLincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management
Maynard, G., Kulasa, K., Ramos, P., Childers, D., Clay, B., Sebasky, M., Fink, E., Field, A., Renvall, M., Juang, P. S., et al. (2015) · Endocrine Practice · doi:10.4158/ep14367.or · Cited by 52
Alvarado, A. M., & Navarro, S. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4078695 · Cited by 52
Matsutani, D., Sakamoto, M., Iuchi, H., Minato, S., Suzuki, H., Kayama, Y., Takeda, N., Horiuchi, R., & Utsunomiya, K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0683-2 · Cited by 52
Warncke, K., Kummer, S., Raile, K., Grulich-Henn, J., Woelfle, J., Steichen, E., Prinz, N., & Holl, R. W. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01696 · Cited by 52
Clarke, J., Sanatkar, S., Baldwin, P. A., Fletcher, S., Gunn, J., Wilhelm, K., Campbell, L., Zwar, N., Harris, M., Lapsley, H., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/12246 · Cited by 52
Loffler, K. A., Heeley, E., Freed, R., Meng, R., Bittencourt, L. R., Gonzaga Carvalho, C. C., Chen, R., Hlavac, M., Liu, Z., Lorenzi-Filho, G., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2006 · Cited by 52
Pop‐Busui, R., Backlund, J. C., Bebu, I., Braffett, B. H., Lorenzi, G., White, N. H., Lachin, J. M., Soliman, E. Z., & DCCT/EDIC Research Group (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13635 · Cited by 52
Self-citationFranek, E., Haluzík, M., Canecki Varžić, S., Sargin, M., Macura, S., Zacho, J., & Christiansen, J. S. (2016) · Diabetic Medicine · doi:10.1111/dme.12982 · Cited by 51
Lee, Y.-Y., Lin, Y.-M., Leu, W.-J., Wu, M.-Y., Tseng, J.-H., Hsu, M.-T., Tsai, C.-S., Hsieh, A.-T., & Tam, K.-W. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.011 · Cited by 51
De Feyter, H. M., Praet, S. F., van den Broek, N. M., Kuipers, H., Stehouwer, C. D., Nicolay, K., Prompers, J. J., & van Loon, L. J. C. (2007) · Diabetes Care · doi:10.2337/dc07-0183 · Cited by 51
Selective rather than universal screening for gestational diabetes mellitus?
Miailhe, G., Kayem, G., Girard, G., Legardeur, H., & Mandelbrot, L. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.003 · Cited by 51
Riche, D. M., Valderrama, R., & Henyan, N. N. (2007) · Diabetes Care · doi:10.2337/dc06-1854 · Cited by 51
Use of insulin detemir in pregnancy: A report on 10 type 1 diabetic women
Lapolla, A., Di Cianni, G., Bruttomesso, D., Dalfrà, M. G., Fresa, R., Mello, G., Napoli, A., Romanelli, T., Sciacca, L., Stefanelli, G., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02852.x · Cited by 51
T1DGC, O. B. O. T., Wiebe, J. C., Santana, A., Medina-Rodríguez, N., Hernández, M., Nóvoa, J., Mauricio, D., & Wägner, A. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3376-8 · Cited by 51
Frequency of self-monitoring blood glucose and attainment of HbA1c target values
Elgart, J. F., González, L., Prestes, M., Rucci, E., & Gagliardino, J. J. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0745-9 · Cited by 51
Newswanger, B., Ammons, S., Phadnis, N. V., Ward, W. K., Castle, J. R., Campbell, R. W., & Prestrelski, S. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814565131 · Cited by 51
(2004) · PubMed · Cited by 51
Marincic, P. Z., Salazar, M. V., Hardin, A., Scott, S., Fan, S. X., Gaillard, P. R., Wyatt, C., Watson, L., Green, P., Glover, P., et al. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.06.303 · Cited by 51
Leese, G. P., Stratton, I. M., Land, M., Bachmann, M. O., Jones, C., Scanlon, P., Looker, H. C., & Ferguson, B. (2015) · Diabetes Care · doi:10.2337/dc14-1778 · Cited by 50
Adamuz, J., Viasus, D., Jiménez‐Martínez, E., Isla, P., García‐Vidal, C., Dorca, J., & Carratalà, J. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.02.006 · Cited by 50
Zieve, F. J., WENGER, N. K., Ben‐Yehuda, O., Constance, C. M., Bird, S. R., Lee, R., Hanson, M. E., Jones-Burton, C., & Tershakovec, A. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.029 · Cited by 50
Diabetes and automobile crashes in the elderly. A population-based case-control study
McGwin, G., Sims, R. V., Pulley, L., & Roseman, J. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.220 · Cited by 50
Sharma, A. E., Willard-Grace, R., Hessler, D., Bodenheimer, T., & Thom, D. H. (2016) · The Annals of Family Medicine · doi:10.1370/afm.1924 · Cited by 50
Lam, J. C. M., Lai, A. Y. K., Tam, T. C. C., Yuen, M. M. A., Lam, K. S. L., & Ip, M. S. M. (2017) · Sleep and Breathing · doi:10.1007/s11325-016-1428-7 · Cited by 50
Yackobovitch‐Gavan, M., Wolf Linhard, D., Nagelberg, N., Poraz, I., Shalitin, S., Phillip, M., & Meyerovitch, J. (2018) · Pediatric Obesity · doi:10.1111/ijpo.12263 · Cited by 50
Safety of liraglutide in type 2 diabetes and chronic kidney disease
Mann, J. F. E., Fonseca, V. A., Poulter, N. R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Mosenzon, O., & on behalf of the LEADER Trial Investigators (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11881019 · Cited by 50
Shang, W., Zhang, Y., Wang, G., & Han, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14247 · Cited by 50
Low carbohydrate dietary approaches for people with type 2 diabetes-a narrative review
Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.687658 · Cited by 50
Farrokhi, F., Chandra, P., Smiley, D. D., Pasquel, F. J., Peng, L., Newton, C. A., & Umpierrez, G. E. (2013) · Endocrine Practice · doi:10.4158/ep13131.or · Cited by 49
Self-citationMetformin use and the risk of colorectal adenoma: A systematic review and meta-analysis
Jung, Y. S., Park, C. H., Eun, C. S., Park, D. I., & Han, D. S. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13639 · Cited by 49
Fitzpatrick, S. L., Golden, S. H., Stewart, K., Sutherland, J., DeGross, S., Brown, T., Wang, N.-Y., Allen, J., Cooper, L. A., & Hill-Briggs, F. (2016) · Diabetes Care · doi:10.2337/dc16-0941 · Cited by 49
Ovarian aging in women with diabetes: An overview
Wellons, M. F., Matthews, J. J., & Kim, C. (2017) · Maturitas · doi:10.1016/j.maturitas.2016.11.019 · Cited by 49
A systematic review on insulin overdose cases: Clinical course, complications and treatment options
Johansen, N. J., & Christensen, M. B. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12957 · Cited by 49
Ullal, J., Aloi, J. A., Reyes-Umpierrez, D., Pasquel, F. J., McFarland, R., Rabinovich, M., & Umpierrez, G. E. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817750899 · Cited by 49
Self-citationBruno, G., Merletti, F., Biggeri, A., Bargero, G., Cerai, S. P., Pagano, G., & Cavallo‐Perin, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0195-6 · Cited by 48
Genetic causes and treatment of neonatal diabetes and early childhood diabetes
Barbetti, F., & d’Annunzio, G. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.06.008 · Cited by 48
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0028-1119405 · Cited by 48
Sigal, R. J., Kenny, G. P., Boulé, N. G., Wells, G. A., Prud'homme, D., Fortier, M., Reid, R. D., Tulloch, H., Coyle, D., Phillips, P., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00005 · Cited by 48
Chalk, D., Pitt, M., Vaidya, B., & Stein, K. (2012) · Diabetes Care · doi:10.2337/dc11-2282 · Cited by 48
Ziegler, D., Strom, A., Lobmann, R., Reiners, K., Rett, K., & Schnell, O. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.008 · Cited by 48
Pierce, D. A., Russell, G., & Pirkle, J. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015607559 · Cited by 48
Johnson, S. R., Ellis, J. J., Leo, P. J., Anderson, L. K., Ganti, U., Harris, J. E., Curran, J. A., McInerney-Leo, A. M., Paramalingam, N., Song, X., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12766 · Cited by 48
Pharmacist-led telehealth disease management program for patients with diabetes and depression
Cohen, L. B., Taveira, T. H., Wu, W.-C., & Pirraglia, P. A. (2020) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x18822575 · Cited by 48
Ponce, O. J., Larrea-Mantilla, L., Hemmingsen, B., Serrano, V., Rodríguez‐Gutiérrez, R., Spencer‐Bonilla, G., Álvarez‐Villalobos, N. A., Benkhadra, K., Haddad, A., Gionfriddo, M. R., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00195 · Cited by 48
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12414 · Cited by 48
The financial impact of an inpatient diabetes management service
Haque, W. Z., Demidowich, A. P., Sidhaye, A., Golden, S. H., & Zilbermint, M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01374-0 · Cited by 48
Petersen, E. A., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J., Yu, C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1813 · Cited by 48
Time to eliminate health care disparities in the estimation of kidney function
Williams, W. W., Hogan, J. W., & Ingelfinger, J. R. (2021) · New England Journal of Medicine · doi:10.1056/nejme2114918 · Cited by 48
Tuttle, K. R., Levin, A., Nangaku, M., Kadowaki, T., Agarwal, R., Hauske, S. J., Elsäßer, A., Ritter, I., Steubl, D., Wanner, C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2034 · Cited by 48
Self-citationPittas, A. G., Westcott, G. P., & Balk, E. M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00280-6 · Cited by 47
Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus
Colunga‐Lozano, L. E., Torres, F. J. G., Delgado-Figueroa, N., González‐Padilla, D. A., Hernández, A. V., Roman, Y. M., & Cuello‐García, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011296.pub2 · Cited by 47
Kim, H. J., Jung, S., Kim, J., Yun, T.-J., Kim, J. B., Choo, S. J., Chung, C. H., & Lee, J. W. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0963 · Cited by 47
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Viggiano, E., Viggiano, A., Di Costanzo, A., Viggiano, A., Viggiano, A., Andreozzi, E., Romano, V., Vicidomini, C., Di Tuoro, D., Gargano, G., et al. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3091-4 · Cited by 47
Psaltopoulou, T., Sergentanis, T. N., Ntanasis‐Stathopoulos, I., Tzanninis, I., Riza, E., & Dimopoulos, M. A. (2019) · International Journal of Cancer · doi:10.1002/ijc.32109 · Cited by 47
Wilkinson, L., Yi, N., Mehta, T., Judd, S., & Garvey, W. T. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003232 · Cited by 47
Self-citationAbuannadi, M., Kosiborod, M., Riggs, L. A., House, J. A., Hamburg, M. S., Kennedy, K. F., & Marso, S. P. (2012) · Endocrine Practice · doi:10.4158/ep12196.or · Cited by 46
Self-citationAquatic exercise for adults with type 2 diabetes: a meta-analysis
Rees, J., Johnson, S. T., & Boulé, N. G. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1023-9 · Cited by 46
Metformin for pregnancy and beyond: the pros and cons
Newman, C., & Dunne, F. (2021) · Diabetic Medicine · doi:10.1111/dme.14700 · Cited by 46
Kohl, B., Hammond, M. S., Cucchiara, A. J., & Ochroch, E. A. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.06.021 · Cited by 46
Diabetes mellitus and community-acquired bloodstream infections in the critically ill
McKane, C. K., Marmarelis, M., Mendu, M. L., Moromizato, T., Gibbons, F. K., & Christopher, K. B. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.08.019 · Cited by 46
Jia, X., Zhong, L., Song, Y., Hu, Y., Wang, G., & Sun, S. (2016) · Primary Care Diabetes · doi:10.1016/j.pcd.2015.12.004 · Cited by 46
Flagged first, then by citations
97 of the 1959 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Gillett, 2009, International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes: Diabetes care, Clin Biochem Rev, 30, 197
- 1991, VIII. Study design, progress and performance, Diabetologia, 34, 877
- Nußbaumer, 2016, Ezetimibe-statin combination therapy, Dtsch arztebl int, 113, 445
- Whelton, 2018, Hypertens (Dallas. TX, 71, e13
- 2012, KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int Suppl, 2, 279
- Miller, 2015, Erratum. J Fam Pract, 64, 452
- Mechanick, 2019, Endocr Pract, 25, 1346
- 2019, Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study, Diabetes Care, 42, 601, 10.2337/dc18-1970 · DOI · Paper page
- American Diabetes Association. Medical management of pregnancy complicated by diabetes fourth edition. Jovanovic L, ed. Alexandria, VA: American Diabetes Association, 2009.
Cited by
Sorted by citations
Samson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.02.001 · Cited by 375
Self-citationDisorders of lipid metabolism. Clinical Guidelines 2023
Владиславович, Е. М., Kukharchuk, V. V., Сергиенко, И. В., Alieva, A. S., Antsiferov, M. B., Ansheles, A. A., Arabidze, G. G., Dm, A., Arutyunov, G. P., Ахмеджанов, Н. М., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5471 · Cited by 270
Baricitinib and β-cell function in patients with new-onset type 1 diabetes
Waibel, M., Wentworth, J. M., So, M., Couper, J. J., Cameron, F. J., MacIsaac, R. J., Atlas, G., Gorelik, A., Litwak, S., Sanz-Villanueva, L., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306691 · Cited by 194
Honarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006174 · Cited by 177
Self-citationNadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Self-citation
Metadata
- Authors
- Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., Gardner, T. W., Garg, R., Garvey, W. T., Hirsch, I. B., Hurley, D. L., Izuora, K., Kosiborod, M., Olson, D., Patel, S. B., Pop-Busui, R., Sadhu, A. R., Samson, S. L., Stec, C., Tamborlane, W. V., Tuttle, K. R., Twining, C., Vella, A., Vellanki, P., & Weber, S. L.
- Affiliations
- Ochsner Health System (US)
- Emory University (US)
- Central Michigan University (US)
- Washington University in St. Louis (US)
- University at Buffalo, State University of New York (US)
- Cedars-Sinai Medical Center (US)
- The University of Texas at San Antonio (US)
- Scripps Whittier Diabetes Institute (US)
- University of Michigan (US)
- University of California, Los Angeles (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- Mayo Clinic (US)
- University of Nevada, Las Vegas (US)
- Saint Luke's Hospital (US)
- Colorado Health Foundation (US)
- University of Cincinnati Medical Center (US)
- Houston Methodist (US)
- Mayo Clinic in Florida (US)
- American Association of Clinical Endocrinologists (US)
- Yale University (US)
- Maine Medical Center (US)
- Prisma Health (US)
- ORCID
- Blonde, Lawrence
- Umpierrez, Guillermo E.
- McGill, Janet B.
- Berga, Sarah L.
- Bush, Michael
- Chandrasekaran, Suchitra
- DeFronzo, Ralph A.
- Einhorn, Daniel
- Galindo, Rodolfo J.
- Gardner, Thomas W.
- Garg, Rajesh
- Garvey, W. Timothy
- Hirsch, Irl B.
- Hurley, Daniel L.
- Izuora, Kenneth
- Kosiborod, Mikhail
- Patel, Shailendra B.
- Sadhu, Archana R.
- Samson, Susan L.
- Tamborlane, William V.
- Tuttle, Katherine R.
- Vella, Adrian
- Vellanki, Priyathama
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 28
- Issue
- 10
- Pages
- 923-1049
- ISSN
- 1530-891X (ISSN-L)
- PMC
- PMC10200071
- OpenAlex
- W4291397630
- Cited by
- 507
- References
- 1,959
- Citations by year
- 2026: 95 · 2025: 119 · 2024: 150 · 2023: 134 · 2022: 9
- FWCI
- 76.49
- Type
- journal article
- Language
- en
- Update notices
- erratum (2023-01-01)
- Open access
- bronze
- doi.org
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (K23DK123384, P30DK111024)
- National Institute of Diabetes and Digestive and Kidney Diseases
- BP
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes mellitus, comprehensive diabetes care, glycemic targets, blood glucose monitoring, diabetes complications, obesity, bariatric surgery, hypertension, dyslipidemia, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, cardiovascular disease, prediabetes, type 2 diabetes, type 1 diabetes, insulin therapy, hypoglycemia, diabetes in pregnancy, diabetes education, infertility, dietary supplements, social determinants of health, virtual care, cancer risk, pediatric diabetes care, depression, sleep medicine, team-based care
- MeSH terms
- Child, Diabetes Mellitus, Type 2, Endocrinology, Female, Humans, Hypoglycemic Agents, Insulin, Pregnancy, United States, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-25 (prompt extract-v1).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
